Health Care [ 8/12 ] | Pharmaceuticals [ 29/73 ]
NASDAQ | Common Stock
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.
It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes.
The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses.
Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 7, 25 | -0.19 Decreased by -575.00% | -0.05 Decreased by -280.00% |
| Mar 4, 25 | -0.26 Decreased by -738.00% | 0.02 Decreased by -1.38 K% |
| Nov 7, 24 | -0.48 Decreased by -1.30 K% | 0.04 Decreased by -1.30 K% |
| Aug 8, 24 | 0.26 Decreased by -21.21% | 0.01 Increased by +2.50 K% |
| Aug 8, 24 | 0.04 Decreased by -87.50% | 0.01 Increased by +300.00% |
| May 9, 24 | 0.04 Increased by +150.00% | 0.02 Increased by +100.00% |
| May 9, 24 | 0.04 Increased by +150.00% | 0.02 Increased by +100.00% |
| Mar 6, 24 | 0.33 Increased by +1.20 K% | -0.12 Increased by +375.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 2.00 M Increased by +N/A% | -7.64 M Decreased by -597.53% | Decreased by -382.10% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | -10.19 M Decreased by -176.40% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -19.62 M Decreased by -247.11% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | 9.21 M Increased by +385.91% | Increased by +N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | 1.54 M Increased by +147.67% | Increased by +N/A% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by -100.00% | 13.34 M Increased by +1.22 K% | Increased by +N/A% Increased by +N/A% |
| Nov 30, 23 | 0.00 Decreased by -100.00% | 13.34 M Increased by +1.22 K% | Increased by +N/A% Increased by +N/A% |
| Sep 30, 23 | 0.00 Decreased by -100.00% | -3.22 M Decreased by -79.20% | Decreased by N/A% Decreased by N/A% |